CD19 and psoriasis: The proportion of CD19+CD80+ B cells in PBMCs from patients withpsoriasis vulgaris at the active stage (P<0.001), but not the stationary stage,and all other different psoriasis subtypes (all P<0.01) was upregulated comparedwith HCs.